Web Results

Reprogramming of the tumour microenvironment by stromal PTEN ...

www.ncbi.nlm.nih.gov/pubmed/22179046

Dec 18, 2011 ... ... Trimboli AJ, Martin CK, Li F, Yu L, Fernandez SA, Pécot T, Rosol TJ, Cory S, ... Marsh CB, Yee LD, Jimenez RE, Nuovo G, Lawler SE, Chiocca EA, ... and upregulation of one of its direct targets, ETS2 (v-ets erythroblastosis ...

Enhanced detection and comprehensive in situ phenotypic ... - NCBI

www.ncbi.nlm.nih.gov/pmc/articles/PMC4694973/

Jul 29, 2015 ... ... between subtraction enrichment (SE) vs anti-EpCAM capture strategy ...... Zhang HZ, Jiang F, Spitz MR, Blowers DP, Jimenez CA, Mehran RJ, et al. ... Pecot CV, Bischoff FZ, Mayer JA, Wong KL, Pham T, Bottsford-Miller J, ...

Frontiers | Mutation-related differences in exploratory, spatial, and ...

journal.frontiersin.org/article/134305

Apr 21, 2015 ... Lurchers are characterized by ataxia (Fortier et al., 1987), spatial ..... B6CBA wild type) as well as for between-strain comparisons of cerebellar mutants (CM; pcd vs. ..... Jimenez-Diaz et al., 2004; for review, see Thompson and Steinmetz, ..... Harris, A., Morgan, J. I., Pecot, M., Soumare, A., Osborne, A., and ...

The Regulation of Synaptic Vesicle Recycling by cGMP- Dependent ...

www.jneurosci.org/content/34/26/8788.full.pdf

Jun 25, 2014 ... teaux and Pecot-Dechavassine, 1970; Sudhof, 2004). ... tained stimulation (Ló pez-Jiménez et al., 2009). ..... 3.12% in cGKII KD vs 39.30.

Clinical relevance of circulating cell-free ... - BioMed Central

www.biomedcentral.com/track/pdf/10.1186/s12943-016-0536-0?site=molecular-cancer.biomedcentral.com

Miles et al. identified 17 miRNAs that were dysregulated in HGSOCs in ..... Bowtell DD, Böhm S, Ahmed AA, Aspuria PJ, Bast Jr RC, Beral V, et al. Rethinking ... Yang D, Sun Y, Hu L, Zheng H, Ji P, Pecot CV, et al. Integrated ..... Kapetanakis NI, Uzan C, Jimenez-Pailhes AS, Gouy S, Bentivegna E, Morice P, et al. Plasma ...

Overcoming Intratumor Heterogeneity of Polygenic Cancer Drug ...

www.sciencedirect.com/science/article/pii/S1476558612800637

[13] Choudhary R, Li H, Winn RA, Sorenson AL, Weiser-Evans MC, and Nemenoff RA ... [14] Clauss A, Ng V, Liu J, Piao H, Russo M, Vena N, Sheng Q, Hirsch MS, ... Itaba S, Ito T, Nakata K, Yu J, Kayashima T, Souzaki R, Tajiri T, et al . ..... [154] Ladhani O, Sanchez-Martinez C, Orgaz JL, Jimenez B, and Volpert OV (2011).

Cancer Subclonal Genetic Architecture as a Key to Personalized ...

www.sciencedirect.com/science/article/pii/S1476558613800103

Dec 3, 2013 ... [25] Fendrich V, Schneider R, Maitra A, Jacobsen ID, Opfermann T, and .... [48] Ladhani O, Sánchez-Martinez C, Orgaz JL, Jimenez B, and Volpert OV (2011). .... Nishimura M, Mora EM, Lee JW, Stone RL, Pecot CV, et al.

PDF(592K) - Wiley Online Library

onlinelibrary.wiley.com/doi/10.1111/cas.12030/pdf

Nov 8, 2012 ... Yokobori et al. ..... 1/3 (33%). Tumorigenicity. Injection cell number. (B). T u mor v olume. 0 .... 10 Agirre X, Jimenez-Velasco A, San Jose-Eneriz E et al. ... 31 Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK.

Safety and Efficacy Clinical Trials for SYL1001, a Novel Short ...

iovs.arvojournals.org/article.aspx?articleid=2588575

Leonardi A, Van Setten G, Amrane M, et al. ... Moreno-Montanes J, Sádaba B, Ruz V, et al. ... Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK.

Thierry Pécot - Serpico - Inria

serpico.rennes.inria.fr/doku.php?id=people:tpecot:index

H.Z. Chen, M.M. Ouseph, J. Li, T. Pécot, V. Chokshi, L. Kent, S. Bae, M. Byrne, ... M. Hallett, M. Park, M.G. Piper, C.B. Marsh, L.D. Yee, R.E. Jimenez, G. Nuovo, S.E. .... T. Pécot, Modélisation et estimation du trafic intracellulaire par tomographie ...